<DOC>
	<DOCNO>NCT00604071</DOCNO>
	<brief_summary>estimate sensitivity HMP test identify visual field functional defect subject CNV secondary AMD</brief_summary>
	<brief_title>Sensitivity Home Macular Perimeter ( HMP )</brief_title>
	<detailed_description>The HMP device intend aid patient identify visual abnormality addition symptom Amsler grid use aid prompt referral eye care professional examination clinical diagnosis make . As goal clinical plan demonstrate patient CNV demonstrate visual field abnormality test HMP</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<criteria>Capable willing sign consent form participate study subject AMD related lesion : New onset ( 60 day ) nontreated CNV Age &gt; 50 year VA habitual correction &gt; 20/200 study eye Familiar computer usage Evidence macular disease AMD glaucoma study eye Presence significant medium opacity precludes clear view macular area identify study eye biomicroscopy , CFP , FA Any nonmacular relate ocular surgery perform within 3 month prior study entry target eye Inability tolerate intravenous FA Participation another study exclusion AREDS study</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>HMP , CNV , PHP , HPHP , AMD</keyword>
</DOC>